SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 301.29 |
Enterprise Value ($M) | 360.19 |
Book Value ($M) | 38.79 |
Book Value / Share | 0.71 |
Price / Book | 7.77 |
NCAV ($M) | -56.18 |
NCAV / Share | -1.03 |
Price / NCAV | -5.36 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.13 |
Return on Assets (ROA) | -0.09 |
Return on Equity (ROE) | -0.32 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 2.62 |
Current Ratio | 2.79 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 55.41 |
Assets | 150.38 |
Liabilities | 111.59 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 80.75 |
Operating Income | -1.93 |
Net Income | -20.13 |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -14.26 |
Cash from Investing | -75.53 |
Cash from Financing | 96.50 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13D/A | Caligan Partners LP | 33.20 | 0.00 | |
13D/A | Velan Capital Investment Management LP | 27.20 | 6.22 | |
13G/A | Lytton Laurence W | 4.20 | -26.78 | |
13G/A | HBM Healthcare Investments (Cayman) Ltd. | 0.90 | 0.00 | |
13G/A | Stonepine Capital Management, LLC | 9.99 | -0.07 | |
13G/A | Altium Capital Management LP | 5.00 | -10.88 | |
13G/A | Boothbay Fund Management, Llc | 6.10 | -33.14 | |
13G/A | Morgan Stanley | 1.80 | 37.52 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
400,191 | 5,201,697 | 7.69 | |
48,561 | 1,173,349 | 4.14 | |
664,475 | 1,496,245 | 44.41 | |
312,079 | 1,008,897 | 30.93 | |
(click for more detail) |
Similar Companies | |
---|---|
ACRV – Acrivon Therapeutics, Inc. | ADMA – ADMA Biologics, Inc. |
AFMD – Affimed N.V. | ALT – Altimmune, Inc. |
ANIP – ANI Pharmaceuticals, Inc. |